• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Jon Newsome, USA

    Jon Newsome, USA

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Purningam Jacob, India

    Purningam Jacob, India

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Animesh Kumar, India

    Animesh Kumar, India

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mike Cels, Canada

    Mike Cels, Canada

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Steve

    Steve

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Liam Dwyer, England

    Liam Dwyer, England

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login